🇺🇸 Intravitreal bevacizumab and dexamethasone implant Injection in United States

Intravitreal bevacizumab and dexamethasone implant Injection (Intravitreal bevacizumab and dexamethasone implant Injection) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intravitreal bevacizumab and dexamethasone implant Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intravitreal bevacizumab and dexamethasone implant Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intravitreal bevacizumab and dexamethasone implant Injection in United States?

Yeungnam University College of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.